We are live on ! Find out more
SC

Sapient Capital Portfolio holdings

AUM $7.64B
1-Year Est. Return 51.51%
This Fund
S&P 500
This Quarter Est. Return
+21.19%
1 Year Est. Return
+51.51%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$7.64B
AUM Growth
+$1.01B
Cap. Flow
-$124M
Cap. Flow %
-1.62%
Top 10 Hldgs %
64.66%
Holding
483
New
40
Increased
103
Reduced
165
Closed
87

Top Buys

Rank Stock Value
1
MS icon
Morgan Stanley
MS
+$33.9M
2
CHDN icon
Churchill Downs
CHDN
+$32.2M
3
BKNG icon
Booking.com
BKNG
+$27.4M
4
STLD icon
Steel Dynamics
STLD
+$27M
5
ASND icon
Ascendis Pharma A/S
ASND
+$21.5M

Top Sells

Rank Stock Value
1
APP icon
Applovin
APP
+$75.1M
2
HBNC icon
Horizon Bancorp
HBNC
+$37.1M
3
EQT icon
EQT Corp
EQT
+$33.2M
4
GE icon
GE Aerospace
GE
+$23.8M
5
INTU icon
Intuit
INTU
+$16.5M

Sector Composition

Rank Sector Weight
1 Miscellaneous 25.83%
2 Healthcare 24.64%
3 Technology 14.89%
4 Communication Services 12.7%
5 Financials 5.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AKBA icon
401
Akebia Therapeutics
AKBA
$247M
– –
-200,000
Closed -$278K
ALB icon
402
Albemarle
ALB
$16.2B
– –
-2,692
Closed -$484K
APD icon
403
Air Products & Chemicals
APD
$68.2B
– –
-1,158
Closed -$336K
APH icon
404
Amphenol
APH
$197B
– –
-6,895
Closed -$873K
AZO icon
405
AutoZone
AZO
$48B
– –
-97
Closed -$328K
BA icon
406
Boeing
BA
$164B
– –
-2,349
Closed -$468K
BIIB icon
407
Biogen
BIIB
$32.2B
– –
-1,143
Closed -$210K
BLK icon
408
Blackrock
BLK
$182B
– –
-406
Closed -$390K
BSX icon
409
Boston Scientific
BSX
$67.8B
– –
-9,141
Closed -$574K
CAH icon
410
Cardinal Health
CAH
$54.7B
– –
-2,529
Closed -$534K
CFG icon
411
Citizens Financial Group
CFG
$29.4B
– –
-4,991
Closed -$299K
CLOV icon
412
Clover Health Investments
CLOV
$2.26B
– –
-80,000
Closed -$141K
CMCSA icon
413
Comcast
CMCSA
$95.2B
– –
-24,505
Closed -$704K
COF icon
414
Capital One
COF
$134B
– –
-1,501
Closed -$274K
COO icon
415
Cooper Companies
COO
$13.9B
– –
-3,600
Closed -$257K
COR icon
416
Cencora
COR
$61.5B
– –
-833
Closed -$262K
CORZ icon
417
Core Scientific
CORZ
$5.3B
– –
-13,972
Closed -$209K
CSGP icon
418
CoStar Group
CSGP
$13B
– –
-5,531
Closed -$223K
CTAS icon
419
Cintas
CTAS
$81.9B
– –
-2,987
Closed -$505K
CTRA
420
DELISTED
Coterra Energy
CTRA
– –
-35,393
Closed -$1.24M
CTVA icon
421
Corteva
CTVA
$55.2B
– –
-2,627
Closed -$220K
CVS icon
422
CVS Health
CVS
$120B
– –
-2,836
Closed -$204K
DAL icon
423
Delta Air Lines
DAL
$53B
– –
-5,667
Closed -$377K
DFIV icon
424
Dimensional International Value ETF
DFIV
$21.9B
– –
-5,289
Closed -$279K
DHI icon
425
D.R. Horton
DHI
$40.8B
– –
-49,845
Closed -$6.84M
15 16
17
18 19

Similar funds

WA
Whitebox Advisors Minneapolis, Minnesota $7.65B AUM 13.87% 1-Year Est. Return
SCB
Saudi Central Bank Riyadh, Saudi Arabia $7.63B AUM 53.44% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
CCWA
CLA (CliftonLarsonAllen) Wealth Advisors Minneapolis, Minnesota $7.61B AUM 16.44% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
CIA
Capital Investment Advisors Atlanta, Georgia $7.59B AUM 23.38% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $7.69B AUM 15.48% 1-Year Est. Return
EDRH
Edmond de Rothschild Holding Chambesy, Switzerland $7.59B AUM 23.44% 1-Year Est. Return

Sapient Capital's Q2 2026 Portfolio in Review

As of Q2 2026, Sapient Capital held 483 positions worth $7.64B, up 15% from $6.63B the previous quarter. Its ten largest holdings account for 65% of the portfolio.

Sapient Capital's Q2 2026 filing shows 40 new, 103 increased, 165 reduced and 87 closed positions. Its largest new stake was Ascendis Pharma A/S: 92,162 shares worth $24.6M. The largest sale was Applovin, an estimated $75.1M.

By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 26% a quarter earlier, followed by Healthcare and Technology.

  • Sapient Capital's largest Q2 2026 buy was Ascendis Pharma A/S: 92,162 shares worth $24.6M.
  • Sapient Capital added most to Morgan Stanley in Q2 2026, an estimated $33.9M increase.
  • Sapient Capital's biggest Q2 2026 reduction was Applovin, cutting an estimated $75.1M.
  • Sapient Capital fully exited EQT Corp in Q2 2026, selling an estimated $33.2M.
  • Sapient Capital's ten largest holdings make up 65% of its $7.64B portfolio in Q2 2026.
  • Sapient Capital opened 40 new positions and closed 87 in Q2 2026.
  • Sapient Capital's portfolio value rose 15% quarter-over-quarter to $7.64B.

Based on Sapient Capital's 13F filing for Q2 2026, filed 9 Jul 2026.